Cargando…
Nanopharmaceutics: Part II—Production Scales and Clinically Compliant Production Methods
Due the implementation of nanotechnologies in the pharmaceutical industry over the last few decades, new type of cutting-edge formulations—nanopharmaceutics—have been proposed. These comprise pharmaceutical products at the nanoscale, developed from different types of materials with the purpose to, e...
Autores principales: | Souto, Eliana B., Silva, Gabriela F., Dias-Ferreira, João, Zielinska, Aleksandra, Ventura, Fátima, Durazzo, Alessandra, Lucarini, Massimo, Novellino, Ettore, Santini, Antonello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153617/ https://www.ncbi.nlm.nih.gov/pubmed/32143286 http://dx.doi.org/10.3390/nano10030455 |
Ejemplares similares
-
Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU
por: Souto, Eliana B., et al.
Publicado: (2020) -
Nanopharmaceuticals for Eye Administration: Sterilization, Depyrogenation and Clinical Applications
por: Zielińska, Aleksandra, et al.
Publicado: (2020) -
Abelmoschus esculentus (L.): Bioactive Components’ Beneficial Properties—Focused on Antidiabetic Role—For Sustainable Health Applications
por: Durazzo, Alessandra, et al.
Publicado: (2018) -
Nanopharmaceuticals (part 1): products on the market
por: Weissig, Volkmar, et al.
Publicado: (2014) -
Nanopharmaceuticals (part 2): products in the pipeline
por: Weissig, Volkmar, et al.
Publicado: (2015)